Careers  |  Sign In  |  Register  |   Twitter

Latest in Nephrology

Reuters Health • The Doctor's Channel Daily Newscast

Inappropriate dual ACE/ARB use common, risky

NEW YORK (Reuters Health) – The combination of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB) is often prescribed for elderly patients who do not have trial-established indications for its use, a Canadian population-based study shows. Randomized controlled...

Reuters Health • The Doctor's Channel Daily Newscast

Value of percutaneous revascularization of renal artery stenosis questionable

NEW YORK (Reuters Health) – Percutaneous balloon angioplasty with stenting of renal artery stenosis (RAS) added to medical therapy reduces the need for antihypertensive medication slightly, but otherwise has no effect on clinical outcomes, the results of a new meta-analysis indicate. “Although surgical...

Reuters Health • The Doctor's Channel Daily Newscast

Lower BP targets may not help people with CKD

NEW YORK (Reuters Health) – Current evidence is still inconclusive as to whether patients with chronic kidney disease (CKD) may benefit from aggressive blood pressure control, according to a new review. The study, published in the Annals of Internal Medicine, did not find improved clinical outcomes –...